Abscess
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
inflamed epidermal cyst. A na-ejikọta ntụpọ ojii na cyst dị n'okpuru.
Ụdị dị njọ nke Abscess nwere ike ịhapụ ọnya. Obere erythema gburugburu ọnya na-egosi na ọrịa ahụ nọ na ọnọdụ mkpebi.
Abscess ― ụbọchị ise ka mgbawa na mmiri gachara
References
Ọtụtụ ndị mmadụ na-aga ụlọ mberede maka ọrịa anụ ahụ nke nje bacteria kpatara. Staphylococcus aureus bụ nje bụ́ isi na-akpata ọrịa ndị a, ọ na-esikwa ike ịgwọta ya n'ihi na community-associated methicillin-resistant Staphylococcus aureus (MRSA) pụtara.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Enwere ike kewaa Staphylococcus aureus ụzọ abụọ dabere na nzaghachi ha na ọgwụ nje: methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) . N'ime iri afọ ole na ole gara aga, n'ihi evolushọn nje bacteria na iji ọgwụ nje eme ihe n'ụzọ gabigara ókè, nguzogide S. Aureus na ọgwụ ọjọọ na-arị elu, na-ebute mmụba zuru ụwa ọnụ na ọnụ ọgụgụ ọrịa MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
Ihe na-ebutekarị ha bụ ọrịa nje. Nje bacteria na-emekarị bụ Staphylococcus aureus na-eguzogide methicillin. A na-eme nchọpụta nke ọzịza nke akpụkpọ ahụ na-adabere n'ụdị ọ dị ma kwadoro ya site n'imeghe ya. Ihe onyonyo nke ultrasound nwere ike ịba uru n'ọnọdụ ebe nchoputa ahụ edoghị anya. Na abscesses gburugburu ike, kọmputa tomography (CT) nwere ike dị mkpa ịchọ maka omimi ọrịa.
Ọkọlọtọ ọgwụgwọ maka ọtụtụ ọnya anụ ahụ ma ọ bụ dị nro na-egbutu ya imeghe na igbapu mmiri mgbe ị na-eji ọgwụ nje. Iji agịga na-amịpụta ọtụ adịghị ezughị oke.
Akpụkpọ anụ ahụ na-adịkarị ma bụrụ nke a na-ahụkarị n'afọ ndị na-adịbeghị anya. Ihe ndị dị ize ndụ gụnyere iji ọgwụ eme ihe na eriri afọ, yana ọnụego akọwara ihe ruru 65% n'etiti ndị ọrụ. Na 2005 na United States, nde mmadụ 3.2 gara ngalaba mberede maka ọzịza. N'Australia, ihe dị ka mmadụ 13,000 nọ n'ụlọ ọgwụ na 2008 nwere ọnọdụ ahụ.
○ Ọgwụgwọ
Ịgwọ abscesses na ọgwụ ndị a na-ere ahịa na-esi ike n'ọtụtụ ọnọdụ. Ọ bụrụ na mgbaàmà dị ka ahụ ọkụ na oyi na-apụta n'ahụ niile, biko kpọtụrụ dọkịta ozugbo enwere ike.